Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor

Virology

Volumn 283, Issue 2, 2001, Pages 178-187

  Zhu, Nongliao ^a   Ware, Carl F ^b   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

HEPATITIS C VIRUS;

EID: 0035837040     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0896     Document Type: Article

References (63)

1. The natural history of community-acquired hepatitis C in the United States
2. Hepatitis C virus core protein interacts with 14-13-3 protein and activates the kinase raf-1
3. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNA receptor activation
4. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
5. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
6. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
7. Mechanisms of hepatic toxicity I. TNF-induced liver injury
8. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
9. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor
10. The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA
11. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
12. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis
13. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
14. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury
15. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme
16. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesize bacteriophage T7 RNA polymerase
17. Concanavalin A-induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor
18. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis
19. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells
20. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K
21. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
22. Hepatitis C virus core protein: Carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase
23. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
24. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation
25. Use of the human elongation factor 1a promoter as a versatile and efficient expression system
26. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
27. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
28. Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution
29. Activation of p53 tumor suppressor by hepatitis C virus core protein
30. MAP3K-related kinase involved in NF-kappa B induction by NTF, CD95 and IL-1
31. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
32. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-b receptor
33. Characterization of HCV structural proteins expressed in various animal cells
34. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
35. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling
36. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
37. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2: Nuclear factor kappa B (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase-stress-activated protein kinase
38. Identification and inhibition of the ICE-CED-3 protease necessary for mammalian apoptosis
39. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
40. Hepatitis C virus core protein enhances p53 function through augmentation of DNA-binding affinity and transcriptional ability
41. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
42. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
43. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
44. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes
45. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein
46. Transcriptional repression of p53 promoter by hepatitis C virus core protein
47. Hepatitis C virus core protein represses p21WAF/Cip1/Sid1 promoter activity
48. Tumor necrosis factor alpha-induced activation, of c-jun N-terminal kinase is mediated by TRAF2
49. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein
50. Apoptosis signaling by death receptors
51. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway
52. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation
53. Ectopic expression of hepatitis C virus core protein differentially regulated nuclear transcription factors
54. A novel domain within the 55 kd TNF receptor signals cell death
55. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product
56. Suppression of TNF-α-induced apoptosis by NF-κB
57. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-F/Apo2-mediated cell death but not gene induction
58. Cell death induction by TNF: A matter of self control
59. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
60. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha
61. Hepatitis C virus core protein interacts with cellular putative RNA helicase
62. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis